SCHEMBL16746465

SCHEMBL16746465

CC1(C)c2ccccc2-c2nc(-c3cccc(-c4ccncc4)c3)nc(-c3cccc(-c4cccc(-c5cccc6c5oc5ccccc56)c4)c3)c21

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 2/20 0.39
PRKDC P78527 5/20 0.38
GGPS1 O95749 1/20 0.35
PTGES2 Q9H7Z7 1/20 0.33
KDM4E B2RXH2 3/20 0.31
ALDH1A1 P00352 3/20 0.31
LMNA P02545 3/20 0.31
HPGD P15428 3/20 0.31
HSD17B10 Q99714 3/20 0.31
SMN1; SMN2 Q16637 2/20 0.31
NPC1 O15118 1/20 0.31
MAPT P10636 1/20 0.31
MAPK1 P28482 1/20 0.31
RAB9A P51151 1/20 0.31
POLB P06746 1/20 0.30
KMT2A Q03164 1/20 0.30
AVPR1A P37288 1/20 0.30
PIK3CD O00329 1/20 0.30
PIK3CB P42338 1/20 0.30
PRMT5 O14744 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16746420 1.00 ALOX5 (0.39) ALOX5PRKDCGGPS1PTGES2KDM4E
SCHEMBL16746495 1.00 ALOX5 (0.39) ALOX5PRKDCGGPS1PTGES2KDM4E
SCHEMBL16746255 0.96 ALOX5 (0.42) ALOX5PRKDCGGPS1PTGES2KDM4E
SCHEMBL16746418 0.96 ALOX5 (0.42) ALOX5PRKDCGGPS1PTGES2KDM4E
SCHEMBL16746409 0.95 ALOX5 (0.39) ALOX5PRKDCGGPS1PTGES2KDM4E
SCHEMBL16746312 0.95 ALOX5 (0.37) ALOX5PRKDCGGPS1PTGES2KDM4E
SCHEMBL16746417 0.94 ALOX5 (0.42) ALOX5PRKDCGGPS1PTGES2ALDH1A1
SCHEMBL16746455 0.94 ALOX5 (0.42) ALOX5PRKDCGGPS1PTGES2ALDH1A1
SCHEMBL16746491 0.94 ALOX5 (0.42) ALOX5PRKDCGGPS1PTGES2ALDH1A1
SCHEMBL16746237 0.94 ALOX5 (0.42) ALOX5PRKDCGGPS1PTGES2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11050027-B2 Condensed cyclic compound and organic light-emitting device including the same SAMSUNG ELECTRONICS CO., LTD. (KR) 2021-06-29 US disclosed
US-20150144924-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG SDI CO., LTD. (KR) 2015-05-28 US disclosed
US-20150144924-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG SDI CO., LTD. (KR) 2015-05-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11050027-B2 Condensed cyclic compound and organic light-emitting device including the same CCNT1, CRY1, CCNA1 ALOX5 2061/4885PRKDC 4857/4885GGPS1 746/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.